NSE - Delayed Quote INR

Jubilant Pharmova Limited (JUBLPHARMA.NS)

867.85
-13.20
(-1.50%)
At close: 3:29:59 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
70,227,000
66,448,000
62,193,000
60,591,650
59,638,760
Cost of Revenue
24,997,000
24,221,000
22,228,000
17,869,880
17,534,520
Gross Profit
45,230,000
42,227,000
39,965,000
42,721,770
42,104,240
Operating Expense
37,935,000
36,996,000
37,666,000
34,477,260
30,917,520
Operating Income
7,295,000
5,231,000
2,299,000
8,244,510
11,186,720
Net Non Operating Interest Income Expense
-2,345,000
-2,462,000
-1,784,000
-1,430,350
-1,760,000
Pretax Income
7,209,000
1,705,000
278,000
6,304,470
8,710,760
Tax Provision
977,000
978,000
927,000
2,174,310
2,972,180
Net Income Common Stockholders
6,272,000
771,000
-610,000
4,139,360
8,358,690
Diluted NI Available to Com Stockholders
6,272,000
771,000
-610,000
4,139,360
8,358,690
Basic EPS
39.59
4.87
-3.83
26.00
52.48
Diluted EPS
39.49
4.86
-3.83
26.00
52.48
Basic Average Shares
158,452.38
158,505.99
159,147.53
159,174
159,266.46
Diluted Average Shares
158,827.39
158,856.62
159,147.53
159,174
159,266.46
Rent Expense Supplemental
--
49,000
78,000
44,950
49,080
Total Expenses
62,932,000
61,217,000
59,894,000
52,347,140
48,452,040
Net Income from Continuing & Discontinued Operation
6,272,000
771,000
-610,000
4,139,360
8,358,690
Normalized Income
4,594,054.10
1,951,900
-158,500
4,160,474.39
5,906,510.23
Interest Income
--
261,000
98,000
24,510
80,970
Interest Expense
2,447,000
2,564,000
1,686,000
1,382,410
1,733,570
Net Interest Income
-2,345,000
-2,462,000
-1,784,000
-1,430,350
-1,760,000
EBIT
9,656,000
4,269,000
1,964,000
7,686,880
10,444,330
EBITDA
13,400,000
8,088,000
7,504,000
11,503,920
14,960,810
Reconciled Cost of Revenue
24,997,000
24,221,000
22,228,000
17,869,880
17,534,520
Reconciled Depreciation
3,744,000
3,819,000
5,540,000
3,817,040
4,516,480
Net Income from Continuing Operation Net Minority Interest
6,272,000
771,000
-610,000
4,139,360
5,741,160
Total Unusual Items Excluding Goodwill
1,941,000
-1,687,000
-645,000
-32,230
-250,990
Total Unusual Items
1,941,000
-1,687,000
-645,000
-32,230
-250,990
Normalized EBITDA
11,459,000
9,775,000
8,149,000
11,536,150
15,211,800
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
263,054.10
-506,100
-193,500
-11,115.61
-85,639.77
3/31/2021 - 7/1/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,141.20
-1.40%
 
IPCALAB.NS Ipca Laboratories Limited
1,361.80
+0.91%
 
LUPIN.NS Lupin Limited
2,037.40
+1.12%
 
LAURUSLABS.BO Laurus Labs Limited
588.90
+0.49%
 
SUVENPHAR.NS Cohance Lifesciences Limited
1,077.80
+1.66%
 
SHILPAMED.NS Shilpa Medicare Limited
638.90
+0.48%
 
IOLCP.NS IOL Chemicals and Pharmaceuticals Limited
62.20
-0.27%
 
AJANTPHARM.NS Ajanta Pharma Limited
2,537.90
+0.75%
 
ALKEM.NS Alkem Laboratories Limited
4,946.50
+0.14%
 
SUNPHARMA.BO Sun Pharmaceutical Industries Limited
1,744.85
-1.21%